The utility of functional interaction and cluster analysis in CNS proteomics

Proteomic studies offer enormous potential for gaining insight into cellular dynamics and disease processes. An immediate challenge for enhancing the utility of proteomics in translational research lies in methods of handling and interpreting the large datasets generated. Publications rarely extend beyond lists of proteins, putatively altered derived from basic statistics. Here we describe two additional distinct approaches (with particular strengths and limitations) that will enhance the analysis of proteomic datasets. Arithmetic and functional cluster analyses have been performed on proteins found differentially regulated in human glioma. These two approaches highlight (i) subgroups of proteins that may be co-regulated and play a role in glioma pathophysiology, and (ii) functional protein interactions that may improve comprehension of the biological mechanisms involved. A coherent proteomic strategy which involves both arithmetic and functional clustering, (together with careful consideration of conceptual limitations), is imperative for quantitative proteomics to deliver and advance the biological understanding of disease of the CNS. A strategy which combines arithmetic analysis and bioinformatics of protein-protein interactions is both generally applicable and will facilitate the interpretation of proteomic data.

[1]  M. Eravci,et al.  Results and reliability of protein quantification for two‐dimensional gel electrophoresis strongly depend on the type of protein sample and the method employed , 2008, Proteomics.

[2]  J. Robben,et al.  Treatment of missing values for multivariate statistical analysis of gel‐based proteomics data , 2008, Proteomics.

[3]  J. Mcculloch,et al.  Proteomic analysis of gliomas , 2007, British journal of neurosurgery.

[4]  C. Vulpe,et al.  Déjà vu in proteomics. A hit parade of repeatedly identified differentially expressed proteins , 2008, Proteomics.

[5]  S. Atlas,et al.  Magnetic resonance image–guided proteomics of human glioblastoma multiforme , 2003, Journal of magnetic resonance imaging : JMRI.

[6]  Vani Santosh,et al.  Differential protein expression in human gliomas and molecular insights , 2005, Proteomics.

[7]  R. Stupp,et al.  The Role of Radio- and Chemotherapy in Glioblastoma , 2005, Oncology Research and Treatment.

[8]  Proteome analysis of cortical neuronal cultures following cycloheximide, heat stress and MK801 preconditioning , 2005, Proteomics.

[9]  O. Bogler,et al.  Proteomics: the new frontier also for brain tumor research. , 2008, Current problems in cancer.

[10]  F. Zanella,et al.  Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial. , 2006, The Lancet. Oncology.

[11]  Karl J. Friston,et al.  Comparing Functional (PET) Images: The Assessment of Significant Change , 1991, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[12]  I. Whittle,et al.  Randomized Phase III controlled trials of therapy in malignant glioma: where are we after 40 years? , 2008, British journal of neurosurgery.

[13]  John D. Storey A direct approach to false discovery rates , 2002 .

[14]  Emilio Marengo,et al.  Application of partial least squares discriminant analysis and variable selection procedures: a 2D-PAGE proteomic study , 2008, Analytical and bioanalytical chemistry.

[15]  D. Dominguez,et al.  Proteomics: Clinical Applications , 2007, American Society for Clinical Laboratory Science.

[16]  Bruno Zanotti,et al.  Proteomic studies on low- and high-grade human brain astrocytomas. , 2005, Journal of proteome research.

[17]  Rony Seger,et al.  The MEK/ERK cascade: from signaling specificity to diverse functions. , 2007, Biochimica et biophysica acta.

[18]  A. Vortmeyer,et al.  Protein patterns and proteins that identify subtypes of glioblastoma multiforme , 2004, Oncogene.

[19]  E. Krause,et al.  The whereabouts of transmembrane proteins from rat brain synaptosomes during two‐dimensional gel electrophoresis , 2008, Proteomics.

[20]  M. Oshimura,et al.  Proteomics-based identification of differentially expressed genes in human gliomas: down-regulation of SIRT2 gene. , 2003, Biochemical and biophysical research communications.

[21]  J. Mcculloch,et al.  Effect of Apomorphine on the Relationship between Local Cerebral Glucose Utilization and Local Cerebral Blood Flow (with an Appendix on its Statistical Analysis) , 1982, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[22]  John Sharkey,et al.  Apoptosis induced by staurosporine alters chaperone and endoplasmic reticulum proteins: Identification by quantitative proteomics , 2007, Proteomics.

[23]  A. Vortmeyer,et al.  Proteins and Protein Pattern Differences between Glioma Cell Lines and Glioblastoma Multiforme , 2005, Clinical Cancer Research.

[24]  Aaron S. Gajadhar,et al.  PROTEOMICS: PRESENT AND FUTURE IMPLICATIONS IN NEURO‐ONCOLOGY , 2008, Neurosurgery.

[25]  R. Ramponi,et al.  Clinical applications , 2007, Lasers in Medical Science.

[26]  M. Girolami,et al.  Clinical proteomics: A need to define the field and to begin to set adequate standards , 2007, Proteomics. Clinical applications.

[27]  Houeto Jean-Luc [Parkinson's disease]. , 2022, La Revue du praticien.

[28]  D. Butterfield,et al.  Proteomics in animal models of Alzheimer's and Parkinson's diseases , 2009, Ageing Research Reviews.

[29]  J. Mcculloch,et al.  The effect of diazepam upon local cerebral glucose use in the conscious rat , 1986, Neuroscience.

[30]  Ulrich Mansmann,et al.  Technical strategies to reduce the amount of “false significant” results in quantitative proteomics , 2008, Proteomics.